February 2014 Life Science Industry Research Reports

Geodon (Schizophrenia) – Forecast and Market Analysis to 2022

Published in Feb 2014 ; US $ 3495 Onwards; Publisher: GlobalData

Schizophrenia is a persistent long-term brain disorder that causes severe, debilitating psychotic episodes. Its core symptoms, auditory or visual hallucinations, are often accompanied by fixed, false, and often paranoid beliefs, called delusions. These two features are often combined with learning […]

Risperdal (Schizophrenia) – Forecast and Market Analysis to 2022

Published in Feb 2014 ; US $ 3495 Onwards; Publisher: GlobalData

Schizophrenia is a persistent long-term brain disorder that causes severe, debilitating psychotic episodes. Its core symptoms, auditory or visual hallucinations, are often accompanied by fixed, false, and often paranoid beliefs, called delusions. These two features are often combined with learning […]

Seroquel (Schizophrenia) – Forecast and Market Analysis to 2022

Published in Feb 2014 ; US $ 3495 Onwards; Publisher: GlobalData

Schizophrenia is a persistent long-term brain disorder that causes severe, debilitating psychotic episodes. Its core symptoms, auditory or visual hallucinations, are often accompanied by fixed, false, and often paranoid beliefs, called delusions. These two features are often combined with learning […]

Invega (Schizophrenia) – Forecast and Market Analysis to 2022

Published in Feb 2014 ; US $ 3495 Onwards; Publisher: GlobalData

Schizophrenia is a persistent long-term brain disorder that causes severe, debilitating psychotic episodes. Its core symptoms, auditory or visual hallucinations, are often accompanied by fixed, false, and often paranoid beliefs, called delusions. These two features are often combined with learning […]

Zyprexa (Schizophrenia) – Forecast and Market Analysis to 2022

Published in Feb 2014 ; US $ 3495 Onwards; Publisher: GlobalData

Schizophrenia is a persistent long-term brain disorder that causes severe, debilitating psychotic episodes. Its core symptoms, auditory or visual hallucinations, are often accompanied by fixed, false, and often paranoid beliefs, called delusions. These two features are often combined with learning […]

Latuda (Schizophrenia) – Forecast and Market Analysis to 2022

Published in Feb 2014 ; US $ 3495 Onwards; Publisher: GlobalData

Schizophrenia is a persistent long-term brain disorder that causes severe, debilitating psychotic episodes. Its core symptoms, auditory or visual hallucinations, are often accompanied by fixed, false, and often paranoid beliefs, called delusions. These two features are often combined with learning […]

Fanapt (Schizophrenia) – Forecast and Market Analysis to 2022

Published in Feb 2014 ; US $ 3495 Onwards; Publisher: GlobalData

Schizophrenia is a persistent long-term brain disorder that causes severe, debilitating psychotic episodes. Its core symptoms, auditory or visual hallucinations, are often accompanied by fixed, false, and often paranoid beliefs, called delusions. These two features are often combined with learning […]

Clozaril (Schizophrenia) – Forecast and Market Analysis to 2022

Published in Feb 2014 ; US $ 3495 Onwards; Publisher: GlobalData

Schizophrenia is a persistent long-term brain disorder that causes severe, debilitating psychotic episodes. Its core symptoms, auditory or visual hallucinations, are often accompanied by fixed, false, and often paranoid beliefs, called delusions. These two features are often combined with learning […]

Saphris (Schizophrenia) – Forecast and Market Analysis to 2022

Published in Feb 2014 ; US $ 3495 Onwards; Publisher: GlobalData

Schizophrenia is a persistent long-term brain disorder that causes severe, debilitating psychotic episodes. Its core symptoms, auditory or visual hallucinations, are often accompanied by fixed, false, and often paranoid beliefs, called delusions. These two features are often combined with learning […]